Short-term Outcomes in a Nurse Coordinator-led and Nurse Practitioner-led Sotrovimab Initiative for Solid Organ Transplant Recipients During the Omicron Surge

Transplantation. 2022 Sep 1;106(9):e424-e425. doi: 10.1097/TP.0000000000004217. Epub 2022 Aug 19.

Authors

Willa Cochran^{1

2}, Julie Langlee^{1

2}, Lindsay Barker^{2

3}, Kristin Freed^{2

3}, Allison Brown^{2

3}, Heather McDade^{1

2}, Deb Carter^{2

3}, Lauren Boyer^{1

2}, Susan Sullivan^{2

3}, Kathleen Shagena^{2

3}, Maura Belden^{1

2}, Rachel Marino^{1

2}, Elizabeth Adams^{2

3}, Jae Lee^{2

3}, Michael McCarthy^{2

3}, Kathryn Lee-Young^{2

3}, Sean Ellis^{2

3}, Sheila Young^{2

3}, Michelle Morrison^{1

2}, Carrie Chamberlain Penny^{1

2}, Fawaz Al Ammary^{2

3}, Laura Hartman^{2

3}, Julie Horn^{2

3}, Terri Miller^{2

3}, Susan Miller^{2

3}, Sophia Purekal⁴, Zishan Siddiqui^{3

4}, Dorry L Segev^{1

2}, Daniel C Brennan^{2

3}, Pali Shah^{2

3}, Robin K Avery³

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
² Comprehensive Transplant Center, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
⁴ Baltimore Convention Center COVID Infusion Center, Baltimore, MD.

PMID: 35675440
DOI: 10.1097/TP.0000000000004217

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
Humans
Nurse Practitioners*
Organ Transplantation* / adverse effects
Transplant Recipients

Substances

Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
sotrovimab